Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Conduct Value Index Fund Ira Comparison to weigh expense ratios against returns. Use these insights to build a cost-aware portfolio.
22,505 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A high-profile wedding, a flash of cameras, and a lesson in personal finance. The moment karlie kloss seen leaving of...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...
Bitcoin has seen wild swings, but could it really go to zero? This guide breaks down probabilities, failure scenarios...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Apple appears to have sealed an early victory in the 2026 chip race, securing dominant access to the most advanced pr...
Canopy Growth has slipped while the market rose. This article breaks down the reasons behind the drop, what it means ...
Bitcoin has pulled back from its peak, but history offers clues about what may come next. This practical guide breaks...
A record-breaking bid for SpaceX could reshape the opening trading landscape. Here’s how inflows of demand influence ...
Investors are weighing whether Chevron’s recent steps point to a new growth platform. This deep dive explains what a ...
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Institutional moves can reveal where smart money is flowing. Learn why highmark wealth management buys Axogen stock, ...